Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Lifeloc Technologies, Inc. develops, manufactures, and markets portable hand-held and fixed station breathalyzers and related accessories for law enforcement, workplace, corrections, original equipment manufacturing, and consumer markets worldwide. It offers fuel-cell based breath alcohol testing equipment; and a line of supplies, accessories, services, and training to support customers alcohol testing programs. The company also develops and sells online drug and alcohol training and refresher courses. In addition, it engages in the ownership and rental of real property through existing commercial leases. Further, the company provides Sentinel zero tolerance alcohol screening station; R.A.D.A.R, a real-time alcohol detection and reporting product; and calibration products, as well as breath testing devices. Additionally, it offers EASYCAL automatic calibration station; Phoenix 6.0 evidential breath testers; Lifeloc; and SpinDx. The company was incorporated in 1983 and is headquartered in Wheat Ridge, Colorado. Lifeloc Technologies, Inc. is a subsidiary of EDCO Partners LLLP.
Lifeloc Reports Second Quarter 2026 Results
Lifeloc reported Q2 2026 revenue of $2.445 million, up 10% year-over-year, with gross margin expanding to 45% from 42%.
The net loss narrowed significantly to $(134) thousand, or $(0.05) per diluted share, compared to a net loss of $(394) thousand in the prior year period.
The company initiated beta testing for its SpinDetect oral-fluid analyzer and is targeting a limited commercial launch in Q1 2027.
Lifeloc secured $500,000 in financing from its Chairman and CFO through a term loan with 10.5% interest, secured by all company assets.